Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
50.07
-1.67 (-3.23%)
Mar 31, 2025, 1:29 PM EDT - Market open
Tarsus Pharmaceuticals Employees
Tarsus Pharmaceuticals had 323 employees as of December 31, 2024. The number of employees increased by 79 or 32.38% compared to the previous year.
Employees
323
Change (1Y)
79
Growth (1Y)
32.38%
Revenue / Employee
$566,418
Profits / Employee
-$357,752
Market Cap
1.92B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 323 | 79 | 32.38% |
| Dec 31, 2023 | 244 | 157 | 180.46% |
| Dec 31, 2022 | 87 | 41 | 89.13% |
| Dec 31, 2021 | 46 | 26 | 130.00% |
| Dec 31, 2020 | 20 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
TARS News
- 18 days ago - Tarsus Announces Pricing of Upsized $125.0 Million Public Offering - GlobeNewsWire
- 18 days ago - Tarsus Announces Proposed $100.0 Million Public Offering - GlobeNewsWire
- 20 days ago - Tarsus Pharma: Strong Execution In Xdemvy Commercialization - Seeking Alpha
- 24 days ago - Tarsus to Participate in Upcoming Investor Conference - GlobeNewsWire
- 4 weeks ago - Tarsus Pharmaceuticals, Inc. (TARS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Tarsus to Report Fourth Quarter and Full-Year 2024 Financial Results on Tuesday, February 25, 2025 - GlobeNewsWire
- 2 months ago - Tarsus to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 2 months ago - Tarsus Provides 2025 Update: Accelerating the Launch of XDEMVY® and Establishing Ocular Rosacea as the Next Category-Creating Opportunity in Eye Care - GlobeNewsWire